Table 2 Antibiotic Practices for Fistula Surgery
From: Current practices in treatment of female genital fistula: a cross sectional study
| Â | N | % |
|---|---|---|
Antibiotics usually available for pelvic surgery * | Â | Â |
   Aminoglycosides (e.g., gentamicin/tobramycin) | 31 | 78% |
   Quinolones (e.g., ciprofloxacin) | 31 | 78% |
   Second-generation cephalosporins (e.g., cefuroxime) | 15 | 38% |
   Third-generation cephalosporins (e.g., ceftriaxone) | 22 | 55% |
   "Rescue" antibiotics for multi-resistant organisms (e.g., imipenem) | 2 | 5% |
Factors influencing availability of antibiotics^ | Â | Â |
   Market factors: drug availability and hospital budget | 12 | 30% |
   Hospital formulary set by administration | 11 | 28% |
   Ministry of Health's essential drug list | 8 | 20% |
   Donation from partners | 4 | 10% |
   Other | 4 | 10% |
   No response | 1 | 3% |
Use of prophylactic antibiotics^ | Â | Â |
   For every fistula case | 23 | 58% |
   For selected fistula cases | 14 | 35% |
   Never | 2 | 5% |
   No response | 1 | 3% |
Most important factor in choice of prophylactic antibiotics^ | Â | Â |
   Recommendations of medical literature | 9 | 23% |
   Surgeon training in vesicovaginal fistula surgery | 9 | 23% |
   Availability | 7 | 18% |
   Personal choice | 5 | 13% |
   Cost | 2 | 5% |
   Does not use prophylactic antibiotics | 1 | 3% |
   Other | 7 | 18% |